SG11201605860SA - Perfusion media - Google Patents
Perfusion mediaInfo
- Publication number
- SG11201605860SA SG11201605860SA SG11201605860SA SG11201605860SA SG11201605860SA SG 11201605860S A SG11201605860S A SG 11201605860SA SG 11201605860S A SG11201605860S A SG 11201605860SA SG 11201605860S A SG11201605860S A SG 11201605860SA SG 11201605860S A SG11201605860S A SG 11201605860SA
- Authority
- SG
- Singapore
- Prior art keywords
- perfusion media
- perfusion
- media
- Prior art date
Links
- 230000010412 perfusion Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461933665P | 2014-01-30 | 2014-01-30 | |
PCT/US2015/013524 WO2015116820A1 (en) | 2014-01-30 | 2015-01-29 | Perfusion media |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201605860SA true SG11201605860SA (en) | 2016-08-30 |
Family
ID=53678412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201605860SA SG11201605860SA (en) | 2014-01-30 | 2015-01-29 | Perfusion media |
Country Status (13)
Country | Link |
---|---|
US (2) | US10047141B2 (en) |
EP (2) | EP3683316A1 (en) |
JP (2) | JP6749838B2 (en) |
KR (1) | KR20160113710A (en) |
AU (2) | AU2015210930B2 (en) |
BR (1) | BR112016017630A2 (en) |
CA (1) | CA2937965A1 (en) |
EA (2) | EA037238B1 (en) |
ES (1) | ES2784775T3 (en) |
IL (2) | IL246816B (en) |
MX (2) | MX362923B (en) |
SG (1) | SG11201605860SA (en) |
WO (1) | WO2015116820A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
ES2784775T3 (en) * | 2014-01-30 | 2020-09-30 | Coherus Biosciences Inc | Perfusion media |
KR20220039777A (en) * | 2019-08-01 | 2022-03-29 | 브리스톨-마이어스 스큅 컴퍼니 | Methods for improving protein productivity in fed-batch cell culture |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7294481B1 (en) | 1999-01-05 | 2007-11-13 | Immunex Corporation | Method for producing recombinant proteins |
CA2508925C (en) * | 2002-12-23 | 2012-08-28 | Bristol-Myers Squibb Company | Product quality enhancement in mammalian cell culture processes for protein production |
US7300773B2 (en) | 2004-08-27 | 2007-11-27 | Wyeth Research Ireland Limited | Production of TNFR-Ig |
US7700739B2 (en) | 2005-06-30 | 2010-04-20 | Abbott Laboratories | IL-12/p40 binding proteins |
AT503429B1 (en) | 2006-08-14 | 2007-10-15 | Sticht Fertigungstech Stiwa | Turntable, has parts carrier, which is provided with guide elements, by which parts carrier is guided along guide tracks, and transfer medium has guide track, along which parts carrier is guided by one of guide elements |
WO2008024769A2 (en) * | 2006-08-21 | 2008-02-28 | Raven Biotechnologies, Inc. | Intensified perfusion production method |
MX2009004519A (en) * | 2006-11-03 | 2009-05-12 | Wyeth Corp | Glycolysis-inhibiting substances in cell culture. |
KR20090127326A (en) * | 2007-03-02 | 2009-12-10 | 와이어쓰 | Use of copper and glutamate in cell culture for production of polypeptides |
US8039231B2 (en) * | 2008-04-17 | 2011-10-18 | Wyeth Llc | Methods for enhanced production of bone morphogenetic proteins |
HUE048980T2 (en) * | 2009-08-11 | 2020-08-28 | Hoffmann La Roche | Production of proteins in glutamine-free cell culture media |
US9540426B2 (en) * | 2009-10-06 | 2017-01-10 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
WO2011134920A1 (en) | 2010-04-26 | 2011-11-03 | Novartis Ag | Improved cell culture medium |
WO2012023085A1 (en) * | 2010-08-20 | 2012-02-23 | Wyeth Llc | Cell culture of growth factor-free adapted cells |
JP2013536683A (en) * | 2010-08-31 | 2013-09-26 | フリエスランド ブランズ ビー.ブイ. | Culture medium for eukaryotic cells |
KR102108663B1 (en) | 2011-07-01 | 2020-05-07 | 암젠 인크 | Mammalian cell culture |
JP2015509704A (en) * | 2011-12-30 | 2015-04-02 | アッヴィ・インコーポレイテッド | Dual variable domain immunoglobulins for receptors |
NZ629178A (en) * | 2012-02-29 | 2016-09-30 | Gilead Biologics Inc | Antibodies to matrix metalloproteinase 9 |
EP2823034A1 (en) * | 2012-03-08 | 2015-01-14 | Friesland Brands B.V. | Culture medium for eukaryotic cells |
ES2784775T3 (en) * | 2014-01-30 | 2020-09-30 | Coherus Biosciences Inc | Perfusion media |
-
2015
- 2015-01-29 ES ES15742902T patent/ES2784775T3/en active Active
- 2015-01-29 BR BR112016017630A patent/BR112016017630A2/en not_active IP Right Cessation
- 2015-01-29 KR KR1020167023816A patent/KR20160113710A/en not_active Application Discontinuation
- 2015-01-29 MX MX2016009980A patent/MX362923B/en active IP Right Grant
- 2015-01-29 EP EP20162652.0A patent/EP3683316A1/en not_active Withdrawn
- 2015-01-29 AU AU2015210930A patent/AU2015210930B2/en not_active Ceased
- 2015-01-29 JP JP2016549376A patent/JP6749838B2/en active Active
- 2015-01-29 SG SG11201605860SA patent/SG11201605860SA/en unknown
- 2015-01-29 CA CA2937965A patent/CA2937965A1/en not_active Abandoned
- 2015-01-29 EA EA201691542A patent/EA037238B1/en unknown
- 2015-01-29 WO PCT/US2015/013524 patent/WO2015116820A1/en active Application Filing
- 2015-01-29 US US14/609,225 patent/US10047141B2/en active Active
- 2015-01-29 EP EP15742902.8A patent/EP3099324B1/en active Active
- 2015-01-29 EA EA202092845A patent/EA202092845A1/en unknown
-
2016
- 2016-07-18 IL IL246816A patent/IL246816B/en active IP Right Grant
- 2016-07-29 MX MX2019002182A patent/MX2019002182A/en unknown
-
2018
- 2018-08-13 US US16/102,157 patent/US11001623B2/en active Active
-
2019
- 2019-06-20 IL IL267558A patent/IL267558B/en unknown
-
2020
- 2020-03-25 JP JP2020053939A patent/JP2020115867A/en active Pending
- 2020-07-22 AU AU2020207824A patent/AU2020207824A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX362923B (en) | 2019-02-25 |
BR112016017630A2 (en) | 2017-08-08 |
MX2019002182A (en) | 2020-11-12 |
EA201691542A1 (en) | 2016-12-30 |
IL246816A0 (en) | 2016-08-31 |
IL267558B (en) | 2022-02-01 |
US10047141B2 (en) | 2018-08-14 |
KR20160113710A (en) | 2016-09-30 |
JP2017508448A (en) | 2017-03-30 |
WO2015116820A1 (en) | 2015-08-06 |
EP3683316A1 (en) | 2020-07-22 |
ES2784775T3 (en) | 2020-09-30 |
EP3099324A4 (en) | 2017-07-12 |
IL267558A (en) | 2019-08-29 |
US20180346550A1 (en) | 2018-12-06 |
MX2016009980A (en) | 2016-11-15 |
CA2937965A1 (en) | 2015-08-06 |
US11001623B2 (en) | 2021-05-11 |
EP3099324B1 (en) | 2020-04-01 |
IL246816B (en) | 2019-07-31 |
JP2020115867A (en) | 2020-08-06 |
AU2020207824A1 (en) | 2020-08-06 |
EA037238B1 (en) | 2021-02-25 |
EA202092845A1 (en) | 2021-06-30 |
JP6749838B2 (en) | 2020-09-02 |
AU2015210930A1 (en) | 2016-08-04 |
AU2015210930B2 (en) | 2020-04-30 |
EP3099324A1 (en) | 2016-12-07 |
US20150210750A1 (en) | 2015-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245323A1 (en) | Culture medium | |
GB201421094D0 (en) | Culture medium | |
GB201517022D0 (en) | No details | |
GB201409066D0 (en) | Fluid system | |
GB201410907D0 (en) | No details | |
GB201519531D0 (en) | No details | |
GB2521883B (en) | Media controller | |
GB201517404D0 (en) | No details | |
HUE051027T2 (en) | Culture medium | |
GB201409065D0 (en) | Fluid system | |
GB201418217D0 (en) | No details | |
GB201418216D0 (en) | No details | |
GB201421817D0 (en) | Secure media player | |
GB201517412D0 (en) | No details | |
ZA201606446B (en) | Filter media construction | |
GB201516796D0 (en) | No details | |
GB201517574D0 (en) | No details | |
IL267558B (en) | Perfusion media | |
GB201513196D0 (en) | Media device | |
GB201517605D0 (en) | No details | |
GB201419650D0 (en) | Modified heterocyclase | |
GB201410910D0 (en) | No details | |
GB201401171D0 (en) | Purification medium | |
PL3183486T3 (en) | Preassembled media line | |
GB201801971D0 (en) | No details |